Pedro Eerdmans

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Stephan Windecker, Patrick W. Serruys, Simon Wandel et al. · The Lancet · 2008 · 652 citations

Medicine, Cardiology, Surgery +17

Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

Philip Urban, Roxana Mehran, Róisín Colleran et al. · European Heart Journal · 2019 · 572 citations · Full text

Medicine, Cardiology, Internal Medicine +16

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

Giulio Stefanini, Bindu Kalesan, Patrick W. Serruys et al. · The Lancet · 2011 · 352 citations

Medicine, Cardiology, Clinical Cardiology +15

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

Patrick W. Serruys, Vasim Farooq, Bindu Kalesan et al. · JACC: Cardiovascular Interventions · 2013 · 331 citations

Medicine, Biomedical Engineering, Cardiology +14

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

Peter Barlis, E. Regar, Patrick W. Serruys et al. · European Heart Journal · 2009 · 248 citations · Full text

Medicine, Biomedical Engineering, Cardiology +14